Filter your results
- 3
- 3
- 3
- 2
- 1
- 3
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
MARCKS as a Potential Therapeutic Target in Inflammatory Breast CancerCells, 2022, 11 (18), pp.2926. ⟨10.3390/cells11182926⟩
Journal articles
hal-03958360v1
|
||
|
The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillanceScience, 2022, 378 (6615), ⟨10.1126/science.abq5358⟩
Journal articles
pasteur-04096669v1
|
||
|
In silico comparative study of SARS-CoV-2 proteins and antigenic proteins in BCG, OPV, MMR and other vaccines: evidence of a possible putative protective effectBMC Bioinformatics, 2021, 22 (1), pp.163. ⟨10.1186/s12859-021-04045-3⟩
Journal articles
pasteur-03574758v1
|